COURAGE 5 years on: The message grows stronger

Heart

Volumn 98, Issue 24, 2012, Pages 1757-1760

  Boden, William E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROME; ANGINA PECTORIS; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DIET; DRUG ELUTING STENT; EDITORIAL; EXERCISE; HEART MUSCLE REVASCULARIZATION; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SMOKING CESSATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; HUMANS; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINES AS TOPIC; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 84870410139     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2012-302823     Document Type: Editorial

References (30)

1. Grüntzig A. Transluminal dilatation of coronary artery stenosis. Lancet 1978;1:263-66.
2. Kushner FG, Hand M, Smith SC, et al. 2009 focused updates; ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guidelines and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (Updating the 2005 guidelines and 2007 focused update). J Am Coll Cardiol 2009;54:2205-41.
3. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361:13-20.
4. Wallentin L, et al. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease Investigators. Lancet 1999;354:708-15.
5. Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med 2001;344:1879-87.
6. Fox KA, Poole-Wilson PA, Henderson RA, et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina. Lancet 2002;360:743-51.
7. Mehta SR, Cannon CP, Fox KAA, et al. Routine versus selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA 2005;293:2908-17.
8. Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronaryartery bypass grafting for severe coronary artery disease. N Engl J Med 2009;360:961.
9. Hannan EL, Racz MJ, Gold J, et al. American College of Cardiology; American Heart Association. Adherence of catheterization laboratory cardiologists to American College of Cardiology/American Heart Association guidelines for percutaneous coronary interventions and coronary artery bypass graft surgery: what happens in actual practice? Circulation 2010;121:67-75.
10. Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI in stable coronary disease. N Engl J Med 2007;35:1503-16.
11. The BARI-2D Study Group. BARI 2D: a randomized clinical trial of treatment strategies for type 2 diabetes and coronary artery disease. N Engl J Med 2009;360:2503-15.
12. Rothberg MB, Sivalingam SK, Ashraf J, et al. Patients' and cardiologists' perceptions of the benefits of percutaneous coronary intervention for stable coronary disease. Ann Intern Med 2010;153:307-13.
13. Fowler FJ Jr, Gallagher PM, Bynum JP, et al. Decisionmaking process reported by Medicare patients who had coronary artery stenting or surgery for prostate cancer. J Gen Intern Med 2012;27:911-16.
14. RITA-2 trial participants. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. RITA-2 trial participants. Lancet 1997;350:461-8.
15. Parisi AF, Folland ED, Hartigan P, on behalf of the Veterans Affairs ACME investigators. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. N Engl J Med 1992;326:10-16.
16. Nishigaki K, Yamazaki T, Kitabatake A. Percutaneous coronary intervention plus medical therapy reduces the incidence of acute coronary syndrome more effectively than initial medical therapy only among patients with low-risk coronary artery disease; a randomized, comparative multicenter study. J Am Coll Cardiol Intv 2008;1:469-79.
17. Katritsis DG, Ioannidis JP. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis. Circulation 2005;111:2906-12.
18. Schomig A, Mehilli J, deWaha A, et al. A meta-analysis of 17 randomized trials of a percutaneous coronary intervention-based strategy in patients with stable coronary artery disease. J Am Coll Cardiol 2008;52:894-904.
19. Jeremias A, Kaul S, Rosengart TK, et al. The impact of revascularization on mortality in patients with non-acute coronary artery disease. Am J Med 2009;122:152-61.
20. Wijeysundera HC, Ko DT. Does percutaneous coronary intervention reduce mortality in patients with stable chronic angina: are we talking about apples and oranges? Circ Cardiovasc Qual Outcomes 2009;2:123-6.
21. Trikalinos TA, Alsheikh-Ali AA, Tatsioni A, et al. Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and network meta-analysis. Lancet 2009;373:911-18.
22. Weintraub WS, Spertus JA, Kolm P, et al. Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med 2008;359:677-87.
23. Stergiopoulos K, Brown DL. Initial coronary stent implantation with medical therapy versus medical therapy alone for stable coronary artery disease: meta-analysis of randomized controlled trials. Arch Intern Med 2012;172:312-19.
24. Borden WB, Redberg RF, Mushlin AI, et al. Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention. JAMA 2011;305:1882-9.
25. Hannan EL, Samadashvili Z, Cozzens K, et al. Comparative outcomes for patients who do and do not undergo percutaneous coronary intervention for stable coronary artery disease in New York. Circulation 2012;125:1870-9.
26. Chan PS, Patel MR, Klein LW, et al. Appropriateness of percutaneous coronary intervention. JAMA 2011;306:53-61.
27. American College of Cardiology Foundation. 2012. Internal analysis of NCDR CathPCI Registry Data from July 1, 2009 through September 30, 2011.
28. Boden WE. Mounting evidence for lack of PCI benefit in stable ischemic heart disease: what more will it take to turn the tide of treatment? Arch Intern Med 2012;172:319-21.
29. De Bruyne B, Pijls NHJ, Kalesan B, et al. Fractional Flow Reserve-Guided PCI versus Medical Therapy in Stable Coronary Disease. N Engl J Med 2012;367:991-1001.
30. Boden WE. Which Is More Enduring - FAME or COURAGE? N Engl J Med 2012;367:1059-61.